Its involvement in energy metabolism as an insulin-sensitizing, anti-inflammatory, and anti-atherogenic molecule is largely admitted [30] and obesity and insulin-resistant states have been associated with reduced plasma adiponectin concentrations [4]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.